TRIM47 promotes ovarian cancer cell proliferation, migration, and invasion by activating STAT3 signaling. Clinics, [S. l.], v. 77, p. 100122, 2022. DOI: 10.1016/j.clinsp.2022.100122. Disponível em: https://revistas.usp.br/clinics/article/view/213575.. Acesso em: 1 jun. 2024.